ICD-10-CM code · FY2027
F14.988 Cocaine use, unspecified with other cocaine-induced disorder
BillableValid for claims as a specific diagnosis code
About F14.988
- Code
- F14.988
- Billable
- Yes
- Short description
- Cocaine use, unspecified with other cocaine-induced disorder
- Category
- F14 Cocaine related disorders
- Block
- F10-F19 Mental and behavioral disorders due to psychoactive substance use
- Chapter
- 5 Mental, Behavioral and Neurodevelopmental disorders
- Code set
- FY2027, October 1, 2026 to September 30, 2027
EvidencePulse™by 2 Minute Medicine®
Go deeper into cocaine use.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for F14.988
Applicable to Other names for conditions reported with this code.
- Cocaine induced obsessive compulsive or related disorder
Also applies, from F14.9 Cocaine use, unspecified
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Also applies, from F14 Cocaine related disorders
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- other stimulant-related disorders (F15.-)
Chapter 5 notes (apply to every code in it)
Includes Conditions this code covers.
- disorders of psychological development
Related codes in F14.98
Latest research on cocaine use
- Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans
- Heterogenous pattern of cocaine usage in the United States
- Contingency management programs linked to decreased cocaine use among adults
- Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
- 2 Minute Medicine: Pharma Roundup – Geopolitical instability in the Strait of Hormuz threatens global generic drug supply, daraxonrasib improves pancreatic cancer survival, sparsentan (Filspari) approved for focal segmental glomerulosclerosis, glucagon-like peptide-1 receptor agonists linked to reduced substance use disorders, and orforglipron (Foundayo) expands oral weight loss therapy options
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app